Related Experiment Video
Updated: Jan 4, 2026

08:09
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
8.5K
iRhom2 and TNF: Partners or enemies?
Marina Badenes1, Colin Adrain1,2
1Instituto Gulbenkian de Ciência (IGC), Oeiras, Portugal. mbadenes@igc.gulbenkian.pt cadrain@igc.gulbenkian.pt.
Science Signaling
|October 31, 2019
Summary
iRhom2 protects against liver fibrosis by regulating TNF receptor shedding. This study reveals iRhom2
Area of Science:
- Cell biology
- Molecular medicine
- Gastroenterology
Background:
- iRhom2 is a cofactor for ADAM17, a metalloprotease involved in shedding TNF-α and TNFRs.
- Dysregulated TNF receptor signaling contributes to liver fibrosis.
Purpose of the Study:
- To investigate the role of iRhom2 in liver fibrosis.
- To elucidate the mechanism by which iRhom2 influences TNFR shedding in hepatic stellate cells.
Main Methods:
- Cell culture of hepatic stellate cells.
- Analysis of ADAM17-mediated protein shedding.
- Assessment of TNFR signaling pathways.
- In vivo models of liver injury and fibrosis.
Main Results:
- iRhom2 promotes ADAM17-mediated shedding of TNFRs in hepatic stellate cells.
- Reduced TNFR signaling was observed due to iRhom2-dependent shedding.
- iRhom2 demonstrated a protective role against liver fibrosis in response to injury.
Conclusions:
- iRhom2 plays a critical protective role in mitigating liver fibrosis.
- Targeting the iRhom2-ADAM17 axis may offer a therapeutic strategy for liver fibrosis.
Related Concept Videos
T Cell Types and Functions
2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
416
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
416
TGF - β Signaling Pathway
10.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

